Product range includes BPC-157, available as a standalone peptide or in a blended formulation: (1) M.J.Hsieh et al (2016) Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation Journal of Molecular Medicine, 15 November 2016, Volume 95, pages 323333
Image Source: Deposit Photos Author: mesiluk Image ID: 745476024
That status is not the same as approval for human use, and marketing them for human consumption is what regulators act against
These findings not only enrich the molecular understanding of senescent cell clearance but also provide a novel strategy for precise targeting of endothelial cell senescence in therapeutic applications
Halminen J, Sattar N, Rawshani A et al (2022) Range of risk factor levels, risk control, and temporal trends for nephropathy and end-stage kidney disease in patients with type 1 and type 2 diabetes